Diana Karpman

Medicine & Life Sciences

1. Hemolytic-Uremic Syndrome 100%
2. Shiga Toxin 85%
3. Atypical Hemolytic Uremic Syndrome 68%
4. Thrombotic Thrombocytopenic Purpura 57%
5. Kidney 54%
6. Enterohemorrhagic Escherichia coli 46%
7. Escherichia coli O157 42%
8. Complement Activation 41%
9. Blood Platelets 34%
10. Kinins 30%
11. eculizumab 29%
12. Escherichia coli Infections 27%
13. Thrombotic Microangiopathies 26%
14. Vasculitis 25%
15. Mutation 23%
16. Infections 23%
17. Shiga-Toxigenic Escherichia coli 23%
18. Immunoglobulin A 22%
19. Shiga Toxin 2 21%
20. Complement Factor H 21%
21. Extracellular Vesicles 21%
22. Urinary Tract Infections 20%
23. Pyelonephritis 20%
24. streptococcal M protein 19%
25. Inflammation 19%
26. Child 18%
27. von Willebrand Factor 18%
28. Neutrophils 17%
29. Endothelial Cells 16%
30. Virulence Factors 15%
31. Blood Cells 15%
32. ADAMTS13 Protein 13%
33. Thrombosis 13%
34. Platelet Activation 13%
35. Complement Membrane Attack Complex 13%
36. Hemolysis 13%
37. Renal Insufficiency 12%
38. Complement Factor I 12%
39. Shiga Toxins 11%
40. Bacteriuria 11%
41. Membranoproliferative Glomerulonephritis 11%
42. Interleukin-8 Receptors 11%
43. Urinary Tract 10%
44. Lipopolysaccharides 10%
45. Blood Vessels 9%
46. Toll-Like Receptor 4 9%
47. Cytokines 9%
48. Epithelial Cells 9%
49. Leukocytes 9%
50. Alternative Complement Pathway 9%